Status:
UNKNOWN
Universal Germline Testing in the Community
Lead Sponsor:
Invitae Corporation
Conditions:
Cancer
Solid Tumor
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to enroll participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk. At baseline, patients will be asked to provide...
Detailed Description
This study seeks to enroll adult participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk using Invitae's Multi-Cancer gene panel. ...
Eligibility Criteria
Inclusion
- Patient has consented to germline genetic testing
- Patient has a histologically confirmed diagnosis of a solid tumor cancer
- Patient is willing to release previously collected tissue sample
- Patient is willing to provide research blood samples
- Patient must be at least 18 years of age
Exclusion
- Patient is unable to consent.
- Patient with hematologic malignancy
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05416710
Start Date
June 1 2022
End Date
June 1 2025
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolina Blood and Cancer Care Associates, PA'
Rock Hill, South Carolina, United States, 29732